Page 287 - Drug Class Review
P. 287
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Watkins et al. 80 Year: 1994 Country: US Alzheimer’s Association Inc., Chicago, IL; National Institute on Aging, Washington, DC; Parke- Davis/Warner-Lambert Co, Ann Arbor, MI; Advanced Nutritional Technologies, Elizabeth, NJ Study design: Retrospective data-analysis of RCTs Number of patients: 2,446 To analyze the hepatic effects of TAC treatment in patients with AD Three published trials: Davis et al. 1992; Farlow et al. 1992; Knapp et al 1994 Data from two unpublished trials by coauthor Knapp also included 1992-1994 Placebo-controlled trials of TA
Final Report Update 1 Adverse Events STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN META-ANALYSIS TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
